Bioharvest Sciences (BHST) Receivables - Net (2023 - 2025)

Bioharvest Sciences' Receivables - Net history runs 3 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Receivables - Net rose 77.51% year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $2.0 million, a 77.51% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 77.51% from the prior year.
• Receivables - Net advanced to $2.0 million in Q4 2025 per BHST's latest filing, from $1.4 million in the prior quarter.
• Across five years, Receivables - Net topped out at $2.0 million in Q4 2025 and bottomed at $808000.0 in Q4 2023.
• The 3-year median for Receivables - Net is $1.2 million (2024), against an average of $1.3 million.
• Biggest YoY gain for Receivables - Net was 78.34% in 2025; the steepest drop was 18.4% in 2025.
• Year by year, Receivables - Net stood at $808000.0 in 2023, then soared by 38.12% to $1.1 million in 2024, then jumped by 77.51% to $2.0 million in 2025.
• Per Business Quant, the three latest BHST Receivables - Net figures stand at $2.0 million (Q4 2025), $1.4 million (Q3 2025), and $1.6 million (Q2 2025).